Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Case Rep Womens Health ; 35: e00429, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35855949

ABSTRACT

Rudimentary horn pregnancies are rare but are associated with high mortality and morbidity. The diagnosis can be difficult as it may be challenging to distinguish a rudimentary horn pregnancy from an intrauterine pregnancy on ultrasound. Magnetic resonance imaging can often be used to confirm a rudimentary horn pregnancy. When a second-trimester rudimentary horn pregnancy is diagnosed, surgical intervention should be performed to avoid uterine rupture and hemoperitoneum. The correct diagnosis and management of rudimentary horn pregnancies help to preserve the fertility of younger patients. This case report describes a second-trimester rudimentary horn pregnancy that was diagnosed by ultrasound and magnetic resonance imaging. It was then surgically resected via laparotomy. This patient maintained her fertility and was able to conceive naturally, leading to an uncomplicated term pregnancy.

2.
Cleve Clin J Med ; 86(5): 300-301, 2019 05.
Article in English | MEDLINE | ID: mdl-31066670
5.
Semin Intervent Radiol ; 35(1): 23-28, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29628612

ABSTRACT

As the reversible contraceptive arm implants grow more popular, there is an increasing need to recognize the complications resulting from implant migration and removal. This review summarizes the findings of imaging and removal methods. When an implant is lost, the axillary region should be investigated first. If the implant still cannot be found, visualization though different methods have been employed for non-radiopaque implants. Real-time fluoroscopic-guided localization and removal can be accomplished for radiopaque Nexplanon. Once the implant has been located, standard removal method and other modified techniques can be used to safely remove the implant depending on the implant's location.

6.
Am J Med ; 131(6): 702.e1-702.e5, 2018 06.
Article in English | MEDLINE | ID: mdl-29408216

ABSTRACT

In the United States, 12,000 women are diagnosed with cervical cancer each year, even though the screening for this disease is safe and effective. There are 3 types of screening options available: cervical cytology (Papanicolaou or "Pap" test), Pap/HPV (human papillomavirus) co-test, and HPV-only test. With simplified options such as HPV-only screening, providers who have been reluctant to incorporate cervical cancer screening into their primary care practice may feel more comfortable with offering these services to women. In this article we review the different cervical cancer screening options that are now available and summarize the various changes in guidelines over the last decade.


Subject(s)
Early Detection of Cancer/methods , Uterine Cervical Neoplasms/diagnosis , Adult , Aged , Female , Humans , Middle Aged , Uterine Cervical Neoplasms/epidemiology , Uterine Cervical Neoplasms/prevention & control , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...